Rather than one-medication-fits-all, precision medicine practitioners design specific disease treatments, management and prevention strategies based on high-resolution genetic and clinical data, such as genetic variations and imaging data. With decades of experience, Codex’s team has been working relentlessly with doctors and researchers in identifying diseases and providing personalized treatment solutions for patients.

Genetic testing is pivotal in detecting and managing genetic disorders and diseases, there are four areas that are particularly useful.

1. Diagnostic testing: To verify or to rule out whether you are carrying a specific genetic disorder.
2. Disease Carrier testing: Determine the risk of passing a genetic condition to your child, even if you do not have the condition yourself.
3. Pharmacogenetics: For patients with chronic diseases, genetic test can identify the best treatment plan for you, including the most effective and beneficial medication and dosage.
4. Pre-symptomatic and predictive testing: if you have a family history of a genetic condition, genetic testing prior to you displaying symptoms may show if you possess the risk of developing the genetic disorder, which will aid with early planning and treatment to combat it if it does manifest later on.

Next-Generation Sequencing (NGS) can be used to analyze DNA and RNA samples and holds many advantages over other microarray methods. Importantly, with NGS, an entire human genome can be sequenced within a single day; contrastingly, the previous Sanger sequencing technology required over a decade to deliver similar results. This means our clients, using NGS, can enjoy our genetic testing results at a much faster pace compared to alternative methods of genetic testing; as widely understood, time is crucial in the context of genetic diseases as the sooner a diagnosis, the sooner and more effective a treatment. Professionals will also acknowledge that NGS boasts a higher dynamic range of signal, requires less DNA/RNA as input, does not require a priori knowledge of the genome or genomic features, and has higher reproducibility compared to other variants. Overall, NGS thus possesses better throughput, scalability, and speed than its respective counterparts, making its use a worthwhile decision and investment.